June 15, 2023 US and UK policy responses to the challenges of repurposing approved drugs for new indications
June 14, 2023-February 8, 2024 CeBil Symposium The CeBil symposium marks the conclusion of the Novo Nordisk Foundation’s Collaborative Research Program in Biomedical Innovatio
June 13, 2023 C-Path’s PSTC Receives Positive FDA Response for Drug-Induced Pancreatic Injury Biomarkers Safety biomarkers aim to provide an additional tool for detecting acute drug-induced pancreatic injury (DIPI) in phase 1 clinical
June 12, 2023 Fosfomycin for Non-Urinary Tract Infections: a systematic review Although fosfomycin is currently approved for treating urinary tract infections, it is increasingly being used as salvage...
June 12, 2023 Podcast: Sharing Data to Improve Patient-Focused Outcomes Critical Path Institute’s Dr. Diane Stephenson joined host Alaina Webster to discuss the importance of data sharing to improve..
June 8, 2023 View Now: GUIDs and De-Identification Tools for Rare Diseases C-Path’s Rare Disease Cures Accelerator-Data and Analytics Platform is pleased to present this new webinar, GUIDs and De-Identi
June 8, 2023 C-Path and I-ACT Collaborate on EHR Data Transfer A Major Milestone for Pediatric Real-World Data Project TUCSON, Ariz., June 8, 2023 — Critical Path Institute‘s (C-Path) I
June 7, 2023 Newcastle University’s John Walton Muscular Dystrophy Research Centre Contributes Data to C-Path’s RDCA-DAP TUCSON, Ariz., June 7, 2023 — Critical Path Institute (C-Path) announced today that Newcastle University UK’s John Walton Musc
June 7, 2023 Shaping the Global Innovation and Access Landscape for Better Paediatric Medicines: C-Path Becomes Official Partner of WHO TUCSON, Ariz. and AMSTERDAM, June 7, 2023 — Critical Path Institute (C-Path), a leading global nonprofit committed to expediting
June 7, 2023-June 8, 2023 Rare Disease Endpoint Advancement Pilot Program Workshop: Novel Endpoints for Rare Disease Drug Development Panel within a virtual workshop presented by The Duke-Margolis Center for Health Policy, under a cooperative agreement with the U.
